Company Profile
Nuvectis Pharma Stock Price, News & Analysis
- Ticker:
- NVCT
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
19.54 USD (+1.19%)
Close
Last updated: July 27, 2026
252M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, NVCT closed up 1.19% at $19.54. No new same-company headline was identified in the current news window.
Company overview
Business overview
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
Business Model Characteristics
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
Position Within the Biotechnology Landscape
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
Future catalysts
Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK
GSK · Source: GSK plc
- 02
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
LEGN · Source: Legend Biotech Corporation
- 03
- 04
- 05
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nuvectis Pharma (NVCT)?
Nuvectis Pharma (NVCT) most recently closed at 19.54 USD, a +1.19% move versus the previous session.
What is the market cap of Nuvectis Pharma (NVCT)?
Nuvectis Pharma currently has a market capitalization of 252M USD on BioPharmSignal.
What does Nuvectis Pharma do?
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
On which exchange is NVCT stock listed?
Nuvectis Pharma (NVCT) is associated with NYSE, United States, Biopharma.
What is Nuvectis?
Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story.
Which conditions is Nuvectis Pharma targeting with Nuvectis?
Nuvectis Pharma is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Nuvectis Pharma describe recent progress with Nuvectis?
Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story.
What is Pharma?
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers.